195 related articles for article (PubMed ID: 14747848)
1. Molecule of the month. Ruboxistaurin mesilate hydrate.
Drug News Perspect; 2003 Dec; 16(10):691. PubMed ID: 14747848
[No Abstract] [Full Text] [Related]
2. [Role of PKC in the pathogenesis of diabetic vascular complications].
Inoguchi T; Umeda F
Nihon Rinsho; 2002 Oct; 60 Suppl 10():67-72. PubMed ID: 12430209
[No Abstract] [Full Text] [Related]
3. Ruboxistaurin.
Taulien CA; Joy SV
Drugs Today (Barc); 2006 Sep; 42(9):577-85. PubMed ID: 17028667
[TBL] [Abstract][Full Text] [Related]
4. Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications.
Joy SV; Scates AC; Bearelly S; Dar M; Taulien CA; Goebel JA; Cooney MJ
Ann Pharmacother; 2005 Oct; 39(10):1693-9. PubMed ID: 16160002
[TBL] [Abstract][Full Text] [Related]
5. Ruboxistaurin for diabetic retinopathy.
Gardner TW; Antonetti DA
Ophthalmology; 2006 Dec; 113(12):2135-6. PubMed ID: 17157131
[No Abstract] [Full Text] [Related]
6. Ruboxistaurin mesilate hydrate for diabetic retinopathy.
Schwartz SG; Flynn HW; Aiello LP
Drugs Today (Barc); 2009 Apr; 45(4):269-74. PubMed ID: 19499092
[TBL] [Abstract][Full Text] [Related]
7. [Protein kinase C beta-Inhibitor ruboxistaurin].
Musch A
Med Monatsschr Pharm; 2005 Aug; 28(8):292-3. PubMed ID: 16128544
[No Abstract] [Full Text] [Related]
8. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.
; Aiello LP; Davis MD; Girach A; Kles KA; Milton RC; Sheetz MJ; Vignati L; Zhi XE
Ophthalmology; 2006 Dec; 113(12):2221-30. PubMed ID: 16989901
[TBL] [Abstract][Full Text] [Related]
9. Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetes.
Gilbert RE; Kim SA; Tuttle KR; Bakris GL; Toto RD; McGill JB; Haney DJ; Kelly DJ; Anderson PW
Diabetes Care; 2007 Apr; 30(4):995-6. PubMed ID: 17229944
[No Abstract] [Full Text] [Related]
10. Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema.
Sahu AK; Majji AB
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6890; author reply 6890-1. PubMed ID: 21123772
[No Abstract] [Full Text] [Related]
11. A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.
Casellini CM; Barlow PM; Rice AL; Casey M; Simmons K; Pittenger G; Bastyr EJ; Wolka AM; Vinik AI
Diabetes Care; 2007 Apr; 30(4):896-902. PubMed ID: 17392551
[TBL] [Abstract][Full Text] [Related]
12. Ruboxistaurin (Eli Lilly).
Wheeler GD
IDrugs; 2003 Feb; 6(2):159-63. PubMed ID: 12789620
[TBL] [Abstract][Full Text] [Related]
13. Ruboxistaurin: LY 333531.
Drugs R D; 2007; 8(3):193-9. PubMed ID: 17472415
[TBL] [Abstract][Full Text] [Related]
14. [New prospects in the treatment of diabetic retinopathy. Current situation and pharmacological developments].
Lagrèze WA
MMW Fortschr Med; 2003 Apr; 145(14):37-8. PubMed ID: 15072277
[No Abstract] [Full Text] [Related]
15. Diabetes: the science and the art. Hyperglycemia v complications.
Barbosa J
Arch Intern Med; 1983 Jun; 143(6):1118-9. PubMed ID: 6344824
[No Abstract] [Full Text] [Related]
16. [Causes and treatment of diabetic complications].
Sakamoto N
Nihon Naika Gakkai Zasshi; 1989 Nov; 78(11):1540-3. PubMed ID: 2693554
[No Abstract] [Full Text] [Related]
17. Kidney outcomes in long-term studies of ruboxistaurin for diabetic eye disease.
Tuttle KR; McGill JB; Haney DJ; Lin TE; Anderson PW;
Clin J Am Soc Nephrol; 2007 Jul; 2(4):631-6. PubMed ID: 17699475
[TBL] [Abstract][Full Text] [Related]
18. PKC inhibition and diabetic microvascular complications.
Clarke M; Dodson PM
Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):573-86. PubMed ID: 18054736
[TBL] [Abstract][Full Text] [Related]
19. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
Vinik AI; Bril V; Kempler P; Litchy WJ; Tesfaye S; Price KL; Bastyr EJ;
Clin Ther; 2005 Aug; 27(8):1164-80. PubMed ID: 16199243
[TBL] [Abstract][Full Text] [Related]
20. Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.
Brooks B; Delaney-Robinson C; Molyneaux L; Yue DK
J Diabetes Complications; 2008; 22(2):88-95. PubMed ID: 18280438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
